http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-278141-B6
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-72 |
filingDate | 1988-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c7160798c23f4a385b782221e78540 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8d5b20bd39a59f943432aa975f2c67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d103d5601c646c290577a1a27ee08402 |
publicationDate | 1996-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SK-278141-B6 |
titleOfInvention | Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent |
abstract | Compound of general formula I, is prepared from corresponding 4-hydroxyderivative-chlorothenoxicame with additing at least one equivalent of base with contents of alkaline metal, advantageously 3 to 4 multiple surplus of this base in polar aprotic solvent, inert by reaction conditions, by room temperature to boiling point of reactive solvent under reversible cooler, at which formated salt is parallels introduced to reaction with compound of formula IIIa, for alleviate of reaction is into rea1ctive mixture additing sodium iodide in tiple surplus, with regard on alkylating agent. |
priorityDate | 1987-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.